Select Page

Report Scope:
The scope of the report includes global Liquid Biopsy Research Tools, applications, industry subsegments, biomarker technologies, major funding initiatives, patents, and companies. The market sizes for liquid biopsy diagnostics are given for 2017, 2018 and 2023 (forecasted).

This report reviews liquid biopsy biomarkers and technologies and provides background on why liquid biopsy is increasingly viewed as a replacement for, or a companion to, tissue biopsy. The report then discusses several of the significant large-scale research initiatives that are contributing to liquid biopsy development. Key forces driving the market are enumerated.
The structures of several important industry subsectors are reviewed, as well as major industry acquisitions and strategic alliances from January 2017 through November 2018. Industry subsectors analyzed include advanced sequencing instruments; droplet digital PCR (polymerase chain reaction); target enrichment; single-cell DNA polymerase; non-invasive prenatal testing (NIPT); fetal-cell NIPT; CTC (circulating tumor cell) capture and detection; and liquid biopsy.
The market for liquid biopsy diagnostics is analyzed in depth. The market is analyzed by application (cancer, reproductive health, transplant), biomarker type (nucleic acids, cells, extracellular vesicles, proteins), analysis platform (microarray, NGS, PCR, proteomics, and other), analysis purpose (screening/early detection, diagnosis, therapy guidance, monitoring), and geography (North America, Europe, Asia/Pacific, Rest of World).
Market data covers 2017, 2018 and 2023 (forecasted).
More than 175 companies in the liquid biopsy industry are profiled in this report.
A Summary of the main industry acquisitions and strategic alliances from January 2017 through November 2018, including key alliance trends.
Report Includes:
– 32 data tables and 54 additional tables
– Industry analysis of the liquid biopsy biomarkers and technologies market
– Analyses of global market trends with data from 2017 to 2018, and projections of compound annual growth rates (CAGRs) through 2023
– Characterization and quantification of market potential for liquid biopsy diagnostics by application, biomarker type, analysis platform, analysis purpose and geographical region
– Discussion of several significant large-scale research initiatives that are contributing to liquid biopsy market development
– Examination of various conventional biopsy methods and highlight how liquid biopsy enabling technologies address the issues and are gaining significant traction with key opinion leaders
– Coverage of significant patents and their allotments in each category, as well as major industry acquisitions and strategic alliances data
– Company profiles of major manufacturers and suppliers of liquid biopsy research tools, services and diagnostics, including Agilent Technologies Inc., Cygnus Biosciences, Illumina Inc., Oxford Nanopore, Qiagen, Quantum Biosystems, Roche and Thermo Fisher Scientific
Category: Biotechnology
Related Reports:
Liquid Biopsy with Emphasis on NIPT: Global Markets to 2023
North America Liquid Biopsy Products Market Report (2014-2024) – Market Size, Share, Price, Trend and Forecast
Liquid Biopsy with Emphasis on NIPT: Global Markets to 2023
North America Liquid Biopsy Products Market Report (2014-2024) – Market Size, Share, Price, Trend and Forecast